Insider · CIK 0001414839

Riccitelli Samuel D

Reports to the SEC for 5 companies · WARSAW, IN

sec.gov

Transactions

Companies

Filings

CIK

0001414839

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+11.4K sh	—	—	31,859
2025-05-23	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+8,401 sh	—	—	20,423
2024-05-28	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+2,766 sh	—	—	12,022
2023-06-14	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+1,965 sh	—	—	9,256
2022-06-01	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+1,691 sh	—	—	7,291
2022-02-28	BIOCEPT INCStock Option (right to buy)A Award	Director, Interim President and CEO	AAward	+250K sh	—	—	250,000
2021-07-16	BIOCEPT INCEmployee Stock Option (right to buy)A Award	Director, Interim President and CEO	AAward	+10K sh	—	—	10,000
2021-06-02	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+1,400 sh	—	—	5,600
2020-10-20	BIOCEPT INCEmployee Stock Option (right to buy)A Award	Director, Interim President and CEO	AAward	+10K sh	—	—	10,000
2020-06-03	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+1,400 sh	—	—	4,200
2019-06-05	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+1,400 sh	—	—	2,800
2019-03-18	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2018-06-20	KIDSORTHOPEDIATRICS CORPA Award	Director	AAward	+1,400 sh	—	—	1,400
2018-02-16	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	31,025
2018-02-16	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+77.6K sh	—	—	77,563
2017-09-26	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2016-10-31	VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+200K sh	—	—	674,530
2016-10-31	VRDNViridian Therapeutics, Inc.\DEF Tax Payment	Director, President & CEO	FTax Payment	−103K sh	$0.36	−$37.1K	571,370
2016-10-31	VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−200K sh	—	—	0
2016-06-28	VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+124K sh	—	—	539,365
2016-06-28	VRDNViridian Therapeutics, Inc.\DEF Tax Payment	Director, President & CEO	FTax Payment	−64.8K sh	$0.46	−$29.8K	474,530
2016-06-28	VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−124K sh	—	—	0
2016-03-28	VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsA Award	Director, President & CEO	AAward	+200K sh	—	—	200,000
2016-02-11	VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+124K sh	—	—	469,382
2016-02-11	VRDNViridian Therapeutics, Inc.\DEF Tax Payment	Director, President & CEO	FTax Payment	−54.3K sh	$0.46	−$25K	415,114
2016-02-11	VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−124K sh	—	—	124,251
2015-11-20	VRDNViridian Therapeutics, Inc.\DEP Purchase	Director, President & CEO	PPurchase	+7,000 sh	$0.80	+$5,600	345,130
2015-11-19	VRDNViridian Therapeutics, Inc.\DEP Purchase	Director, President & CEO	PPurchase	+7,000 sh	$0.78	+$5,460	338,130
2015-06-19	VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+124K sh	—	—	377,166
2015-06-19	VRDNViridian Therapeutics, Inc.\DEF Tax Payment	Director, President & CEO	FTax Payment	−46K sh	$1.51	−$69.5K	331,130
2015-06-19	VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−124K sh	—	—	248,503
2015-04-08	VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+373K sh	—	—	372,756
2015-04-08	VRDNViridian Therapeutics, Inc.\DEF Tax Payment	Director, President & CEO	FTax Payment	−120K sh	$2.08	−$249K	252,914
2015-04-08	VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−373K sh	—	—	372,755
2011-03-07	GENOPTIX INCD Disposition to Issuer	Ex VP and COO	DDisposition to Issuer	−8,950 sh	$25.00	−$224K	49
2011-03-07	GENOPTIX INCEmployee Stock Option (right to buy)D Disposition to Issuer	Ex VP and COO	DDisposition to Issuer	−2,368 sh	$10.75	−$25.5K	0
2011-03-07	GENOPTIX INCEmployee Stock Option (right to buy)D Disposition to Issuer	Ex VP and COO	DDisposition to Issuer	−263 sh	$10.75	−$2,827.25	0
2011-03-07	GENOPTIX INCEmployee Stock Option (right to buy)D Disposition to Issuer	Ex VP and COO	DDisposition to Issuer	−2,193 sh	$23.76	−$52.1K	0
2011-03-01	GENOPTIX INCU Disposition from Tender	Ex VP and COO	UDisposition from Tender	−126K sh	$25.00	−$3.15M	8,950
2011-02-28	GENOPTIX INCF Tax Payment	Ex VP and COO	FTax Payment	−3,282 sh	$24.98	−$82K	134,752
2011-02-26	GENOPTIX INCM Exercise/Conversion	Ex VP and COO	MExercise/Conversion	+120K sh	$0.38	+$45.7K	138,034
2011-02-26	GENOPTIX INCEmployee Stock Option (right to buy)M Exercise/Conversion	Ex VP and COO	MExercise/Conversion	−15.9K sh	—	—	0
2011-02-26	GENOPTIX INCEmployee Stock Option (right to buy)M Exercise/Conversion	Ex VP and COO	MExercise/Conversion	−104K sh	—	—	0
2011-02-25	GENOPTIX INCU Disposition from Tender	Ex VP and COO	UDisposition from Tender	−19.9K sh	$25.00	−$498K	17,900
2011-01-03	GENOPTIX INCF Tax Payment	Ex VP and COO	FTax Payment	−2,064 sh	$19.31	−$39.9K	37,828
2010-12-16	GENOPTIX INCA Award	Ex VP and COO	AAward	+10K sh	—	—	39,566
2010-10-01	GENOPTIX INCF Tax Payment	Ex VP and COO	FTax Payment	−919 sh	$14.53	−$13.4K	29,566
2010-07-01	GENOPTIX INCF Tax Payment	Ex VP and COO	FTax Payment	−919 sh	$17.22	−$15.8K	30,485
2010-04-09	GENOPTIX INCM Exercise/Conversion	Ex VP and COO	MExercise/Conversion	+548 sh	$1.24	+$679.52	31,806
2010-04-09	GENOPTIX INCM Exercise/Conversion	Ex VP and COO	MExercise/Conversion	+9,192 sh	$0.38	+$3,492.96	40,998

Recent filings

Accepted (ET)
Jun 104
Riccitelli Samuel D0001425450-26-000058
SEC(opens sec.gov)
May 284
Riccitelli Samuel D0001425450-25-000063
SEC(opens sec.gov)
May 304
Riccitelli Samuel D0001425450-24-000051
SEC(opens sec.gov)
Jun 154
Riccitelli Samuel D0001425450-23-000078
SEC(opens sec.gov)
Jun 34
Riccitelli Samuel D0001425450-22-000062
SEC(opens sec.gov)
Mar 24
Riccitelli Samuel D0001209191-22-015094
SEC(opens sec.gov)
Jul 204
Riccitelli Samuel D0001209191-21-047383
SEC(opens sec.gov)
Jun 44
Riccitelli Samuel D0001425450-21-000095
SEC(opens sec.gov)
Oct 224
Riccitelli Samuel D0001209191-20-055575
SEC(opens sec.gov)
Jun 44
Riccitelli Samuel D0001425450-20-000080
SEC(opens sec.gov)
Jun 74
Riccitelli Samuel D0001425450-19-000064
SEC(opens sec.gov)
Mar 204
Riccitelli Samuel D0001144204-19-015217
SEC(opens sec.gov)
Jun 224
Riccitelli Samuel D0001425450-18-000091
SEC(opens sec.gov)
Feb 214
Riccitelli Samuel D0000899243-18-004801
SEC(opens sec.gov)
Sep 284
Riccitelli Samuel D0000899243-17-022782
SEC(opens sec.gov)
Nov 24
SIGNAL GENETICS, INC.0001209191-16-148044
SEC(opens sec.gov)
Jun 304
SIGNAL GENETICS, INC.0001209191-16-130263
SEC(opens sec.gov)

Companies

Address

C/O ORTHOPEDIATRICS CORP. 2850 FRONTIER DRIVE

WARSAW, IN, 46582